Cara Therapeutics Raises $19 Million

Cara Therapeutics Inc., a < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Tarrytown, N.Y.-based drug company focused on pain and inflammation associated with diverse medical conditions, has raised $19 million in Series C funding. MVM Life Science Partners and Alta Biopharm Partners were joined by return backer Ascent Biomedical Ventures. < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />